Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B

Final draft guidance: 2

Final draft guidance (PDF 256 KB)

Equality impact assessment (downloadable version) (PDF 121 KB)

Public committee slides (PDF 254 KB)

Appeal

Appeal letter : Appeal letter (MSWord 43 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 48 KB)

Scrutiny letter : Scrutiny letter (MSWord 55 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 19 KB)

Appeal letter : Appeal letter (MSWord 84 KB)

Final scrutiny letter : Final scrutiny letter (MSWord 57 KB)

Scrutiny letter : Scrutiny letter (MSWord 57 KB)

Response to scrutiny letter : Response to scrutiny letter (MSWord 108 KB)

Final draft guidance: 1

Final draft guidance (PDF 285 KB)

Public committee slides (PDF 655 KB)

Equality impact assessment (PDF 140 KB)

Draft guidance

Draft guidance (PDF version) (PDF 296 KB)

Public committee slides (PDF 2.12 MB)

Final scope (PDF 158 KB)

Final stakeholder list (PDF 173 KB)

Equality Impact Assessment (Guidance development) (PDF 125 KB)

Draft scope post referral (PDF 186 KB)